Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1957

1.

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.

Goldman LS, Genel M, Bezman RJ, Slanetz PJ.

JAMA. 1998 Apr 8;279(14):1100-7. Review.

PMID:
9546570
[PubMed - indexed for MEDLINE]
2.

A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.

Foy JM, Earls MF.

Pediatrics. 2005 Jan;115(1):e97-104.

PMID:
15629972
[PubMed - indexed for MEDLINE]
3.

Physician perceptions of the use of medications for attention deficit hyperactivity disorder.

Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.

J Manag Care Pharm. 2003 Sep-Oct;9(5):416-23.

PMID:
14613439
[PubMed - indexed for MEDLINE]
Free Article
4.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
[PubMed - indexed for MEDLINE]
5.

Treatment of attention-deficit/hyperactivity disorder.

Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R.

Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341.

PMID:
10790990
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
7.

Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.

Robison LM, Skaer TL, Sclar DA, Galin RS.

CNS Drugs. 2002;16(2):129-37.

PMID:
11825103
[PubMed - indexed for MEDLINE]
8.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
9.

Pharmacotherapy of attention deficit hyperactivity disorder.

Spencer T, Biederman J, Wilens T.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):77-97. Review.

PMID:
10674191
[PubMed - indexed for MEDLINE]
10.

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.

Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD.

J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):797-804.

PMID:
10405496
[PubMed - indexed for MEDLINE]
11.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
[PubMed - indexed for MEDLINE]
12.

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27.

PMID:
15843763
[PubMed - indexed for MEDLINE]
13.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
[PubMed - indexed for MEDLINE]
14.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
[PubMed - indexed for MEDLINE]
15.

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Schubiner H.

CNS Drugs. 2005;19(8):643-55. Review.

PMID:
16097847
[PubMed - indexed for MEDLINE]
16.

Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.

Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.

Aust N Z J Public Health. 2007 Apr;31(2):120-6.

PMID:
17461001
[PubMed - indexed for MEDLINE]
17.

[Prescribing ritalin in combined modality management of hyperactivity with attention deficit].

Bricard C, Boidein F.

Encephale. 2001 Sep-Oct;27(5):435-43. French.

PMID:
11760693
[PubMed - indexed for MEDLINE]
18.

Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S.

J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31. doi: 10.1097/chi.0b013e31815a56f1. Review.

PMID:
18174822
[PubMed - indexed for MEDLINE]
19.

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M.

J Neural Transm Suppl. 2007;(72):311-5.

PMID:
17982908
[PubMed - indexed for MEDLINE]
20.

Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.

Connor DF.

J Dev Behav Pediatr. 2002 Feb;23(1 Suppl):S1-9. Review.

PMID:
11875284
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk